Related Experiment Video
Updated: Aug 10, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Novel avermectins produced by mutational biosynthesis
C J Dutton1, S P Gibson, A C Goudie
1Central Research Division, Pfizer Ltd., Kent, England.
Abstract:
Avermectins with a wide range of novel C-25 substituents have been prepared by feeding carboxylic acids or their biosynthetic precursors to a Streptomyces avermitilis mutant strain ATCC 53568. This organism lacks the ability to form isobutyric and S-2-methylbutyric acids from their 2-oxo acid precursors and thus is unable to produce natural avermectins unless supplied with these acids. The novel avermectins produced by mutational biosynthesis possess broad-spectrum antiparasitic activity.
Related Concept Videos
Viral Mutations
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Physical Properties of Amines
Biosynthesis of Nucleic Acids
Antifungal Agents
Anthelminthic Agents

